Ambry Genetics

Ambry Genetics, established in 1999, is a privately-held American healthcare company led by founder, president, and chairman Charles LM Dunlop, along with CEO Dr. Aaron Elliott. Ambry offers the most comprehensive suite of genetic testing solutions worldwide, applicable to both hereditary and non-hereditary conditions, as well as numerous clinical specialties including oncology, cardiology, pulmonology, neurology, and general genetics. Recognized as a leader in diagnostic solutions for genetic disorders in the U.S., they have conducted over one million genetic tests, identifying more than 45,000 mutations across nearly 500 genes.